Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Preferred Dividend Payments (2022 - 2025)

Historic Preferred Dividend Payments for Fortress Biotech (FBIO) over the last 4 years, with Q3 2025 value amounting to $2.2 million.

  • Fortress Biotech's Preferred Dividend Payments rose 4.6% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.4 million, marking a year-over-year increase of 850.42%. This contributed to the annual value of $9.9 million for FY2024, which is 2316.98% up from last year.
  • As of Q3 2025, Fortress Biotech's Preferred Dividend Payments stood at $2.2 million, which was up 4.6% from $2.1 million recorded in Q1 2025.
  • Fortress Biotech's Preferred Dividend Payments' 5-year high stood at $2.9 million during Q4 2024, with a 5-year trough of $2.0 million in Q2 2022.
  • For the 4-year period, Fortress Biotech's Preferred Dividend Payments averaged around $2.2 million, with its median value being $2.0 million (2022).
  • Per our database at Business Quant, Fortress Biotech's Preferred Dividend Payments surged by 4377.49% in 2024 and then plummeted by 1273.55% in 2025.
  • Over the past 4 years, Fortress Biotech's Preferred Dividend Payments (Quarter) stood at $2.0 million in 2022, then changed by 0.0% to $2.0 million in 2023, then surged by 43.77% to $2.9 million in 2024, then dropped by 24.7% to $2.2 million in 2025.
  • Its last three reported values are $2.2 million in Q3 2025, $2.1 million for Q1 2025, and $2.9 million during Q4 2024.